A review of vinorelbine in the treatment of breast cancer

Clinical Breast Cancer
G H Domenech, Charles L Vogel

Abstract

As combinations and sequences of anthracyclines and taxanes increasingly become standard adjuvant treatment for early breast cancer, a major need for new treatment options for metastatic breast cancer will arise. Vinorelbine is highly active in the treatment of metastatic breast cancer, both as a single agent and in combination regimens. Furthermore, it is well tolerated, with a low incidence of subjective toxicities. It is anticipated, therefore, that vinorelbine will become increasingly utilized for treating metastatic breast cancer due to its favorable safety profile, good tolerability, and promising results in combination with other chemotherapy agents. Combinations with trastuzumab and newer molecular targeting agents are being explored. Doublets or triplets of vinorelbine with drugs other than anthracyclines and taxanes could be considered in the next generation of adjuvant and neoadjuvant trials, where it is anticipated that anthracycline/taxane combinations are likely to replace anthracycline/cyclophosphamide combinations as the mainstay of adjuvant treatment.

References

Aug 15, 1990·International Journal of Cancer. Journal International Du Cancer·S BinetV Meininger
Sep 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J GehlP Dombernowsky
Aug 8, 1998·Breast Cancer Research and Treatment·E BaldiniP Conte
Jun 11, 1999·American Journal of Clinical Oncology·A I ShamseddineN S El Saghir
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D I UdomR C Coombes
Jun 1, 2000·Breast Cancer Research and Treatment·C NisticòE Terzoli
May 30, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M NamerJ L Wendling

❮ Previous
Next ❯

Citations

Dec 19, 2003·Expert Opinion on Pharmacotherapy·Filippo MontemurroMassimo Aglietta
Nov 22, 2002·Cancer Investigation·Catherine Van Poznak, Andrew D Seidman
Feb 20, 2010·La Revue de médecine interne·C Lebrun, M Frenay
Jul 25, 2008·Clinical Breast Cancer·Juan Lucas Bayo-CaleroAlfonso Yubero-Esteban
Jan 17, 2013·The Breast Journal·Ying-Chun XuFeng-Chun Zhang
Jun 16, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CocconiUNKNOWN Italian Oncology Group for Clinical Research (GOIRC), Parma, Italy
Sep 16, 2005·Cancer Chemotherapy and Pharmacology·Rogier R PressOlaf van Tellingen
Jun 16, 2010·Environmental Toxicology·Dimitris Vlastos, Alexandros Ntinopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.